Form D · Other Technology
OXOS MEDICAL, INC.
Atlanta, GA · CIK 0001694304
Offering snapshot reported Dec 19, 2025 · SEC filing
- Reported sold
- $10.7M Offering amount: $28.2M
- Investors reported
- 6 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Dec 12, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 19, 2025 | Initial | $10,706,990 | No comparison | 6 | SEC filing |
| Jan 26, 2023 | Amendment | $8,171,000 | $5,859,000vs Jun 22, 2022 | 3 | SEC filing |
| Jun 22, 2022 | Amendment | $2,312,000 | $463,000vs Apr 21, 2022 | 3 | SEC filing |
| Apr 21, 2022 | Initial | $1,849,000 | No comparison | 1 | SEC filing |
| Feb 24, 2021 | Initial | Yet to sell | No comparison | 0 | SEC filing |
| Sep 28, 2020 | Initial | Yet to sell | No comparison | 0 | SEC filing |
| Feb 21, 2020 | Initial | $4,782,083 | No comparison | 65 | SEC filing |
| Mar 26, 2018 | Initial | $100,000 | No comparison | 2 | SEC filing |
| Aug 4, 2017 | Initial | $150,000 | No comparison | 1 | SEC filing |
| Jan 24, 2017 | Amendment | $650,000 | $600,000vs Jan 12, 2017 | 5 | SEC filing |
| Jan 12, 2017 | Initial | $50,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-567435
Source: Form D, filed Dec 19, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Charlie Bourland, Iii | Director |
| Jesse Coors Blankenship | Director |
| Gregg Hill | Director |
| Joshua B. Hix | Director |
| Greg Kolovich | Director, Executive |
| Gregory Kolovich | Director, Executive |
| Michael Riesen | Executive |
| Evanb Ruff | Executive |
| Evan Ruff | Director, Executive, Promoter |
| Kirby Sisk | Executive |
| James Stubbs | Director |
| Andy Thorson | Director |
| J.A. Thorson | Director |
Issuer details
Industry: Other Technology (See others in industry)
Address:
1100 Peachtree Street Ne Suite 700
Atlanta, GA, 30309
Atlanta, GA, 30309